Compare DRTS & NUTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRTS | NUTX |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | Israel | United States |
| Employees | 121 | 944 |
| Industry | Medical/Dental Instruments | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.0M | 655.4M |
| IPO Year | N/A | 2009 |
| Metric | DRTS | NUTX |
|---|---|---|
| Price | $7.27 | $101.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $8.67 | ★ $252.50 |
| AVG Volume (30 Days) | ★ 205.5K | 133.0K |
| Earning Date | 05-18-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.93 |
| EPS | N/A | ★ 10.48 |
| Revenue | N/A | ★ $875,257,000.00 |
| Revenue This Year | N/A | $8.28 |
| Revenue Next Year | $965.57 | $1.96 |
| P/E Ratio | ★ N/A | $10.09 |
| Revenue Growth | N/A | ★ 82.36 |
| 52 Week Low | $2.50 | $77.21 |
| 52 Week High | $8.60 | $193.07 |
| Indicator | DRTS | NUTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.59 | 49.83 |
| Support Level | $6.37 | $94.38 |
| Resistance Level | $7.75 | $108.47 |
| Average True Range (ATR) | 0.43 | 6.84 |
| MACD | 0.04 | 1.98 |
| Stochastic Oscillator | 69.60 | 61.72 |
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.